Next Article in Journal
Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections
Next Article in Special Issue
The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
Previous Article in Journal
Virtual Reality Distraction during Endoscopic Urologic Surgery under Spinal Anesthesia: A Randomized Controlled Trial
Previous Article in Special Issue
Anti-Mycobacterial Antibodies in Paired Cerebrospinal Fluid and Serum Samples from Japanese Patients with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder
Open AccessReview

Innate Immune Responses and Viral-Induced Neurologic Disease

Division of Microbiology & Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
Author to whom correspondence should be addressed.
All authors contributed equally to this work.
J. Clin. Med. 2019, 8(1), 3;
Received: 2 November 2018 / Revised: 12 December 2018 / Accepted: 18 December 2018 / Published: 20 December 2018
(This article belongs to the Special Issue Potential Pathogenic Mechanisms of Multiple Sclerosis)
Multiple sclerosis (MS) is a disease of the central nervous system (CNS) characterized by chronic neuroinflammation, axonal damage, and demyelination. Cellular components of the adaptive immune response are viewed as important in initiating formation of demyelinating lesions in MS patients. This notion is supported by preclinical animal models, genome-wide association studies (GWAS), as well as approved disease modifying therapies (DMTs) that suppress clinical relapse and are designed to impede infiltration of activated lymphocytes into the CNS. Nonetheless, emerging evidence demonstrates that the innate immune response e.g., neutrophils can amplify white matter damage through a variety of different mechanisms. Indeed, using a model of coronavirus-induced neurologic disease, we have demonstrated that sustained neutrophil infiltration into the CNS of infected animals correlates with increased demyelination. This brief review highlights recent evidence arguing that targeting the innate immune response may offer new therapeutic avenues for treatment of demyelinating disease including MS. View Full-Text
Keywords: virus; innate immunity; neutrophils; demyelination; remyelination virus; innate immunity; neutrophils; demyelination; remyelination
Show Figures

Figure 1

MDPI and ACS Style

Cheng, Y.; Skinner, D.D.; Lane, T.E. Innate Immune Responses and Viral-Induced Neurologic Disease. J. Clin. Med. 2019, 8, 3.

AMA Style

Cheng Y, Skinner DD, Lane TE. Innate Immune Responses and Viral-Induced Neurologic Disease. Journal of Clinical Medicine. 2019; 8(1):3.

Chicago/Turabian Style

Cheng, Yuting; Skinner, Dominic D.; Lane, Thomas E. 2019. "Innate Immune Responses and Viral-Induced Neurologic Disease" J. Clin. Med. 8, no. 1: 3.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop